If you need more lookups,
subscriptions start at $34 USD/month.
Chiara Acone Location
Haarlem, NH, NL
Chiara Acone Work
2021 -now Quality Assessor at Medicines Evaluation Board (CBG-MEB) @
2021 -2021 Associate Director Regulatory Affairs @
2018 -2021 Associate Director Regulatory Affairs - Regulatory CMC Lead - Cell Therapy @
2018 -2018 ad Interim Head of Regulatory Affairs - Senior Manager Regulatory Affairs @
2015 -2018 Regulatory Affairs Team Lead @
2013 -2015 Regulatory Affairs Officer @
2013 -2013 RA Senior Specialist Flu Franchise @
2008 -2013 Regulatory Affairs Officer @
2007 -2007 Senior Pharmaceutical Engineer and PAT @ Solvay Pharmaceuticals
2006 -2007 Research Internship @
Chiara Acone Education
SIR Institute for Pharmacy Practice and Policy
(European Regulatory Affairs (ERA) course)
2011-2012
Leonardo da Vinci program Unipharma Graduates
Doctor of Pharmacy - PharmD
2005
Faculty of Pharmacy, University of Naples “Federico II”, Italy
Master Degree in Pharmaceutical Chemistry and Technologies
2005-2005
Università degli Studi di Napoli Federico II
Chiara Acone Skills
Regulatory Affairs
Regulatory Requirements
Pharmaceutics
Regulatory Submissions
Change Control
GMP
Pharmaceutical Industry
Sop
Pharmacists
Manufacturing site transfers
Customer Service
Pharmacy
Leadership
Research
Data Analysis
Policy
Microsoft Excel
Pharmacy Practice
Life Sciences
Regulatory
Pharmaceutical Sales
Chiara Acone Summary
Chiara Acone, based in Haarlem, NH, NL, is currently a Quality Assessor at Medicines Evaluation Board (CBG-MEB) at College ter Beoordeling van Geneesmiddelen. Chiara Acone brings experience from previous roles at Kyowa Kirin International plc., Kiadis Pharma and Teva Pharmaceuticals. Chiara Acone holds a 2011 - 2012 SIR Institute for Pharmacy Practice and Policy. With a robust skill set that includes Regulatory Affairs, Regulatory Requirements, Pharmaceutics, Regulatory Submissions, Change Control and more. Chiara Acone has 2 emails on RocketReach.
Looking for a different Chiara Acone?
Find contact details for 700 million professionals.